A new study led by a Baycrest clinician-scientist titled “Enhancing Clinical Visibility of Hearing Loss in Cognitive Decline” demonstrated that point of care screening for hearing loss in patients of a memory clinic raised physicians’ awareness of its high prevalence among their patients and led to more frequent referrals for hearing help.
Said to be the “first-of-its-kind study,” based on extensive analyses of autopsied brains, found that Hispanics diagnosed with dementia were much more likely to have cerebrovascular disease than either non-Hispanic whites or African Americans.
These potentially modifiable risk factors—including hearing loss—have been identified at multiple phases across the lifespan, not just in old age. The 'Lancet' Commission's report was simultaneously published in 'The Lancet' and presented at AAIC 2017.
